Hepatopulmonary Syndrome - 18/08/11
Doi : 10.1016/j.cld.2005.07.006
Miguel R. Arguedas, MD, MPH, Michael B. Fallon, MD ⁎ 
Department of Medicine, Division of Gastroenterology/Hepatology, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA
⁎Corresponding author
Résumé |
The hepatopulmonary syndrome is an increasingly important vascular complication of cirrhosis where microvascular dilatation impairs arterial oxygenation in the setting of liver disease. This syndrome is identified in as many as 20% of patients evaluated for liver transplantation and results in increased mortality. No clearly effective medical therapies are available, and liver transplantation is the only established treatment. Pathophysiologic insights obtained from experimental models may lead to the development of novel and effective medical treatments.
Le texte complet de cet article est disponible en PDF.Plan
© 2005
Elsevier Inc. Tous droits réservés.
Vol 9 - N° 4
P. 733-746 - novembre 2005 Retour au numéro
Article précédent
- Management of Ascites in Cirrhosis
- Bimaljit Singh Sandhu, Arun J. Sanyal
- Evaluation and Management of Osteoporosis in Liver Disease
- J. Eileen Hay, Maureen M.J. Guichelaar
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?